DryPowder
Find my investors
Investor listUpdated

4 Biotech investors in New York

As of October 22, 2026, DryPowder lists 4 Biotech venture funds in New York. Their median published check range is $500K–$3M (3 of 4 funds publish one). None has filed a verified SEC Form D in the last 90 days.

Free fund match

Which Biotech funds in New York are writing checks right now?

About 30 seconds. No signup or card needed. Ranked by thesis fit and check size.

funds listed
4
median check (3 of 4 publish one)
$500K–$3M
filed an SEC Form D in the last 90 days
0
last updated, 2026
Oct 22

All 4 Biotech funds in New York

  1. 2048 Ventures
    $500K–$3MSeedPre-Seed

    Thesis-driven early-stage firm backing visionary founders building technologies of the future in Vertical AI, Deep Tech, Health, and Bio with strong…

    4 partners listed
  2. BoxGroup
    $250K–$2.5MSeedSeries A

    Investing in dreams at the earliest stage, backing founders across marketplaces, fintech, developer tools, frontier tech, climate, and experimental…

    Partners not yet listed
  3. Lux Capital
    $500K–$25MSeedGrowth

    Turn sci-fi into sci-fact by championing companies at the intersection of the new and not-yet-imagined, looking decades into the future to create a…

    12 partners listed
  4. Level Ventures
    SeedSeries A

    Capital partner to outlier managers and entrepreneurs, building systems for speed, clarity, and conviction in investment decisions.

    Partners not yet listed

How this list is built

DryPowder lists every fund with a public profile tagged Biotech and headquartered in New York. Funds whose largest published check is $5M or less come first; inside each group, funds with a verified SEC Form D in the last 30 days lead, then profile quality decides. Form D dates come from SEC EDGAR, and SPV and single-deal filings are dropped. Check sizes are what each fund publishes; the median uses only the 3 funds that publish one.

Related investor lists

Other cities

Biotech at other stages

VCs in New York by sector

Hubs

How DryPowder compares

Frequently asked questions

How many Biotech VCs in New York are there?

As of October 22, 2026, DryPowder lists 4 Biotech venture funds in New York with a public profile. The first 4 on this page are 2048 Ventures, BoxGroup, Lux Capital and Level Ventures.

Which Biotech VCs in New York are actively investing right now?

None of the 4 filed a verified SEC Form D in the last 90 days. A Form D is filed when a fund starts raising; SPVs and single-deal vehicles are not counted.

What check size do Biotech VCs in New York write?

The median published range is $500K–$3M, across the 3 of 4 funds that publish a check size. Published checks on this list run from $250K to $25M.

How does DryPowder build this list?

A fund is listed when its public profile is tagged Biotech and its headquarters is New York. Funds whose largest published check is $5M or less come first; within each group, funds that filed a Form D in the last 30 days lead, then profile quality decides. Form D dates come from SEC EDGAR, with SPVs excluded. Data as of October 22, 2026.

Sources

Updated